| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 117.31B | 120.43B | 117.08B | 113.37B | 115.61B | 111.88B |
| Gross Profit | 15.91B | 16.14B | 15.39B | 14.84B | 14.99B | 14.57B |
| EBITDA | 2.57B | 3.00B | 2.62B | 3.22B | 3.88B | 3.94B |
| Net Income | 971.00M | 1.31B | 1.04B | 2.09B | 2.48B | 3.45B |
Balance Sheet | ||||||
| Total Assets | 69.18B | 69.18B | 70.04B | 66.34B | 64.53B | 62.83B |
| Cash, Cash Equivalents and Short-Term Investments | 16.49B | 17.04B | 15.56B | 14.60B | 14.15B | 12.20B |
| Total Debt | 7.41B | 6.11B | 8.09B | 6.37B | 6.19B | 5.37B |
| Total Liabilities | 45.61B | 44.55B | 46.51B | 42.99B | 42.97B | 43.02B |
| Stockholders Equity | 23.53B | 24.59B | 23.50B | 23.32B | 21.53B | 19.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.66B | 996.00M | 1.34B | 1.72B | 3.05B |
| Operating Cash Flow | 0.00 | 4.54B | 1.88B | 3.38B | 1.86B | 3.43B |
| Investing Cash Flow | 0.00 | -278.00M | -1.22B | -1.54B | 364.00M | -532.00M |
| Financing Cash Flow | 0.00 | -2.64B | -278.00M | -1.29B | -376.00M | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥17.99B | 14.38 | ― | 3.75% | 2.86% | 25.43% | |
66 Neutral | ¥128.31B | 18.30 | ― | 3.43% | 0.61% | 8.76% | |
63 Neutral | ¥129.62B | 22.20 | ― | 2.85% | 3.66% | -12.16% | |
62 Neutral | ¥172.72B | 55.15 | ― | 1.58% | 1.63% | 7.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥210.33B | 31.24 | ― | 2.83% | -0.42% | -0.70% | |
52 Neutral | ¥62.35B | 233.26 | 0.36% | 2.78% | -3.62% | 146.18% |